Skip to main content

Calcium antagonists and acute myocardial ischemia: Comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds

Cardiovascular Drugs and Therapy volume 1, pages 367–376 (1987)Cite this article

Summary

The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations. In part I of the study, changes in the time course of spontaneous ventricular arrhythmias and VF parallel to changes in epicardial conduction following acute coronary artery occlusion lasting 20 minutes and followed by subsequent reperfusion were determined. In part II, repeated coronary artery occlusions (20 min) followed by reperfusion (60 min) were performed, and changes in ventricular fibrillation threshold (VFT) were assessed. Gallopamil proved to be highly effective in preventing ventricular arrhythmias and VF following coronary artery occlusion. Simultaneously, peak epicardial conduction delay was reduced. The ischemia-induced fall in VFT occurring during the first few minutes after occlusion (phase Ia) was significantly reduced. In contrast, nifedipine failed to influence the incidence of ventricular arrhythmias and VF.

Following reperfusion, neither drug reduced the incidence of VF nor the associated fall in VFT at the onset of reperfusion. The time course of recovery of epicardial conduction was not affected by either drug. However, the increase in the VFT during the early postreperfusion period was significantly enhanced by both agents. The effects of gallopamil were more pronounced than those of nifedipine. Delayed reperfusion ventricular arrhythmias arising 5 to 10 minutes after release of coronary artery obstruction were significantly reduced by gallopamil whereas nifedipine proved ineffective. The results show that calcium antagonists display direct antiarrhythmic and cardioprotective actions in acute transient myocardial ischemia. The different effectiveness of gallopamil compared to nifedipine can be explained by differences in electrophysiological properties of the drugs. Enhanced ventricular vulnerability following acute transient coronary artery occlusion and subsequent release of coronary artery obstruction, first described by Tennant and Wiggers [1], has been extensively investigated over the past decade in a variety of experimental and clinical settings. However, the basic mechanisms underlying ischemia- and reperfusion-induced ventricular arrhythmias and ventricular fibrillation (VF) have not yet been fully elucidated. Furthermore, the results of pharmacological approaches to prevent ventricular arrhythmic activity are conflicting. The present study aimed to evaluate the antiarrhythmic efficacy of calcium antagonists in acute myocardial ischemia and reperfusion. We have examined the effects of gallopamil and nifedipine on the time course of ventricular arrhythmias during the first 20 minutes after acute coronary artery occlusion and subsequent reperfusion. We have studied the underlying mechanisms by mapping epicardial conduction and by assessing the electrically induced ventricular fibrillation threshold (VFT) both within and outside ischemic areas.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Tennant R, Wiggers CJ. The effect of coronary artery occlusion on myocardial contractions.Am J Physiol 1935;112:351–361.

    Google Scholar 

  2. Lo Hm, Kloner RA, Braunwald E. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment.Am J Cardiol 1985;56:672–677.

    PubMed  Google Scholar 

  3. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride enzyme staining technique.Am Heart J 1981;101:593–600.

    PubMed  Google Scholar 

  4. Gülker H, Thale J, Bender F. Different time course of the ventricular fibrillation threshold following acute coronary artery occlusion and release in ischemic and non-ischemic area of the heart.Pace 1983;6(suppl2):34.

    Google Scholar 

  5. Heuer H, Gülker H, Bender F. Microcomputer-gesteuerte 3-Kanal-Stimulationseinrichtung zur Analyse der atrialen und ventrikulären Vulnerabilität des Herzens.Biomed Tech 1981;26:130–135.

    Google Scholar 

  6. Fleckenstein A.Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. New York: John Wiley & Sons, 1986.

    Google Scholar 

  7. Müller B, Wilsmann K. Effects of the optical isomers of D 600 on cardiovascular parameters and on arrhythmias caused by aconitine and coronary artery ligation in anesthetized rats.J Cardiovasc Pharmac 1982;4:615–621.

    Google Scholar 

  8. Bush LR, Romson JL, Ash JL, Lucchesi. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.J Cardiovasc Pharmac 1982;4:285–296.

    Google Scholar 

  9. Clusin WT, Bristow MR, Baim DS, Schroeder JS, Jaillon P, Brett P, Harrison DC. The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog.Circ Res 1982;50:518–526.

    PubMed  Google Scholar 

  10. Clusin WT, Buchbinder M, Ellis AK, Kernoff RS, Giacomini JC, Harrison DC. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Correlation with improvement of ventricular conduction and early arrhythmias in the dog.Circ Res 1984;54:10–20.

    PubMed  Google Scholar 

  11. Lucchesi B, Patterson E. Effects of diltiazem in conscious canine model of sudden coronary death.Fed Proc 1983;42:845.

    Google Scholar 

  12. Opie LH, Thandroyen FT, Hamm CW, Muller CA, Lloyd EA, Gordon D. Calcium antagonists and the acutely ischemic heart: experimental effects on ventricular fibrillation and enzyme release.Eur Heart J 1938;4(CSuppl):95–100.

    Google Scholar 

  13. Patterson E, Eller BT, Lucchesi BR. Effects of diltiazem upon experimental ventricular dysrhythmias.J Pharmac Exp Ther 1983;225:224–233.

    Google Scholar 

  14. Haverkamp W, Thale J, Gülker H, Hindricks G, Bender F. Comparative investigations on the antiarrhythmic effects of various calcium antagonists following acute transient coronary artery occlusion and reperfusion.Eur Heart J 1987;8(Esuppl), in press.

  15. Meesmann M, Neumann M, Kirchengast M. Influence of the calcium-antagonist gallopamil (D600) on the excitability and conduction time and their dispersions during acute coronary occlusions in dogs. International Symposium on calcium entry blockers and tissue protection, Rome, 1984, abstract.

  16. Crome R, Hearse DJ, Manning AS. Ischemia- and reperfusion-induced arrhythmias: Beneficial action of nifedipine.J Cardiovasc Pharmac 1986;8:1249–1256.

    Google Scholar 

  17. Coker SJ, Parratt JR. Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.J Cardiovasc Pharmac 1983;5:406–417.

    Google Scholar 

  18. Parratt JR, Coker SJ. Cardioprotection with calcium antagonists by suppression of early ischaemia and reperfusion-induced arrhythmias.Eur Heart J 1983;4(supplC):49–54.

    Google Scholar 

  19. Verrier RL, Lown B. Contrasting effects of verapamil and nifedipine on vulnerability to ventricular fibrillation in the normal and ischemic heart. In: Zanchetti A, Krikler DM, eds.Calcium antagonism in cardiovascular therapy. Experience with verapamil. Amsterdam: Excerpta Medica, 1980. Pp.326–337.

    Google Scholar 

  20. Bernauer W. Comparative investiagtions on the effects of metoprolol, propranolol, practolol and verapamil in the acute phase of experimental myocardial infarction.Klin Wochenschr 1982;60:87–96.

    PubMed  Google Scholar 

  21. Bren G, Varghese PJ, Rios J, Katz R, Wasseran A, Ross A. Prevention of ventricular fibrillation by verapamil: Minimum effective dose.Clin Res 1982;30:175A.

    Google Scholar 

  22. Brooks WW, Verrier RL, Lown B. Protective effects of verapamil on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.Cardiovasc Res 1980;14:295–302.

    PubMed  Google Scholar 

  23. Daugherty A, Woodward B. The K+/Ca++ ratio and calcium slow channel antagonists on arrhythmias in the isolated perfused coronary ligated rat heart.Br J Pharmac 1981;72:834P.

    Google Scholar 

  24. Elharrar V, Gaum WE, Zipes DP. Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs.Am J Cardiol 1977;39:544–549.

    PubMed  Google Scholar 

  25. Fondacaro JD, Han J, Yoon MS. Effects of verapamil on ventricular rhythms during coronary occlusion.Am Heart J 1979;96:81–86.

    Google Scholar 

  26. Gülker H, Thale J, Brisse B, Bender F. Vergleichende Untersuchungen zur antiarrhythmischen und antifibrillatorischen Wirksamkeit von Verapamil and Nifedipin nach akutem Koronarverschlub und nach Reperfusion.Z Kardiol 1984;73:515–524.

    PubMed  Google Scholar 

  27. Kaumann AJ, Aramendia P. Prevention of ventricular fibrillation induced by coronary ligation.J Pharmac Exp Ther 1968;164:326–322.

    Google Scholar 

  28. Kaumann AJ, Serur JR. Optical isomers of verapamil on canine heart: prevention of ventricular fibrillation induced by coronary artery occlusion, impaired atrioventricular conductance and negative inotropic and chronotropic effects.Naunyn-Schmiedeberg's Arch Pharmakol 1975;291:374–381.

    Google Scholar 

  29. Kane K, McDonald FM, Parratt Jr. What pharamocological properties are necessary for the prevention of early post-infarction ventricular dysrhythmias.Br J Pharmac 1981;72:512.

    Google Scholar 

  30. Kobayashi A, Nagao B, Nishiyama T, Yamashita T, Ishizaka K, Abe M, Hayashi H, Kamikawa T, Yamazaki N. Antiarrhythmic and myocardial metabolic effects of verapamil during coronary artery reperfusion.Jpn Circ J 1985;49:316–324.

    PubMed  Google Scholar 

  31. Krieger WGF, Fiolet JWT, Willebrands AF, ter Welle HF, van Dam RTH. Sustrate dependence of reoxigenation arrhythmias in the isolated rat heart.Bas Res Cardiol 1980;75:728–738.

    Google Scholar 

  32. Kroll DA, Knight PR. Antifibrillatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias.Anesthesiology 1982;57:A503.

    Google Scholar 

  33. Pelleg A, Pardo Y, Belhassen B, Shargordsky B, Chagnac A, Laniado S. Effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart.Cardiology 1985;72:185–201.

    PubMed  Google Scholar 

  34. Reimer KA, Lowe JE, Jennings RB. Effect of the calcium antagonist verapmil on necrosis following temporary coronary artery occlusion in dogs.Circulation 1977;55:581–587.

    PubMed  Google Scholar 

  35. Schwartz PJ, Vandi E, Zaza A. The prevention of cardiac arrhythmias associated with myocardial ischemia and dependent upon increases in sympathetic activity. In: Zanchetti A, Krikler DM, eds.Calcium antagonism in cardiovascular therapy. Experience with verapamil. Amsterdam: Excerpta Medica, 1981. Pp.314–325.

    Google Scholar 

  36. Schwartz PJ. An experimental approach to the choice of antiarrhythmic therapy.Eur Heart J 1986;7(supplA):135–144.

    PubMed  Google Scholar 

  37. Temesy-Armos P, Legenza M, Hoffman BF. Effects of verapamil on arrhythmias during myocardial ischemia.Am J Cardiol 1982;49:977–982.

    Google Scholar 

  38. Thandroyen FT, Higginson LM, Opie LH. The interaction of calcium and cAMP and the relationship to ventricular vulnerability.Bas Res Cardiol 1981;76:449–452.

    Google Scholar 

  39. Thandroyen FT. Protective action of calcium channel antagonist agents against ventricular fibrillation in the isolated perfused rat heart.J Moll Cell Cardiol 1982;14:21–32.

    Google Scholar 

  40. Watts JA, Maiorano LJ, Maiorano PC. Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury.J Moll Cell Cardiol 1986;18:255–263.

    Google Scholar 

  41. Raschack M, Gries J, Bühler V, Maurer R. Untersuchungen Zur Kardialen und vasalen Wirksamkeit von Gallopamil. In: Kaltenbach M, Hopf R, eds.Galloapmil. Pharmakologisches Wirkungsprofil eines Kalziumantagonisten. Berlin, Heidelberg, New York: Springer, 1983. Pp.75–82.

    Google Scholar 

  42. Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischaemic and reperfused myocardium.Am J Cardiol 1980;46:242–248.

    PubMed  Google Scholar 

  43. Watts JA, Koch CD, LaNoue KF. Effects of Ca2+ antagonism on energy metabolism: Ca2+ and heart function after ischemia.Am J Physiol 1980;238:H909–916.

    PubMed  Google Scholar 

  44. Fleet WF, Johnson TA, Graebner CA, Engle CL, Gettes LS. Effects of verapamil on ischemia-induced changes in extracellular K+, pH, and local activation in the pig.Circulation 1986;73:837–846.

    PubMed  Google Scholar 

  45. Gettes LS, Buchanan JW, Saito T, Kagiyama Y, Oshita S, Fujino T. Studies concerned with slow conduction. In: Zipes DP, Jaliffe J, eds.Cardiac electrophysiology and arrhythmias. New York: Grune and Stratton, 1985. Pp.81–88.

    Google Scholar 

  46. Kramer JB, Corr PB. Mechanisms contributing to arrhythmias during ischemia and reperfusion.Eur Heart J 1984;5(Bsuppl):11–18.

    Google Scholar 

  47. Budden M, Kirchengast M, Zhang KM, Römer B, Meesmann W. Reduced increase of extracellular myocardial potassium activity during acute coronary occlusion in dogs as an effect of the calcium-antagonist gallopamil (D600).Eur J Physiol 1984;400:R5.

    Google Scholar 

  48. Lopez JF, Orchard RC. Effects of verapamil on the extracellular K+ rise during myocardial ischemia in dogs.Cardiovasc Res 1985;19:363–369.

    PubMed  Google Scholar 

  49. Constantin M, Dureng G, Lamar JC, Tisne-Versailles J. Effects of four calcium antagonists on S-T segment elevation and coronary venous efflux of lactate and K+Br J Pharmac 1983;79(suppl):209.

    Google Scholar 

  50. Corr PB, Witkowski FX. Potential electrophysiologic mechanisms responsible for dysrhythmias associated with reperfusion of ischemic myocardium.Circulation 1983;68(supplI):16–24.

    Google Scholar 

  51. Manning AS, Hearse DJ. Reperfusion induced arrhythmias: mechanisms and prevention.J Moll Cell Cardiol 1984;16:497–518.

    Google Scholar 

  52. Sheehan FH, Epstein SE. Effects of calcium channel blocking agents on reperfusion arrhythmias.Am Heart J 1982;103:973–977.

    PubMed  Google Scholar 

  53. Hindricks G, Thale J, Gülker H, Haverkamp W, Kocik J, Bender F. Reperfusion-induced ventricular arrhythmias: electrophysiological and pharmacological implications. In: Santini M, Pistolese M, Alligro A, eds.Progress in clinical pacing. Rome: Centro Editoriale Publicitario Italiano, 1986. Pp. 671–691.

    Google Scholar 

  54. Winslow E, Marshall RJ, Hope FG. Comparative effects of fast and slow-ion channel blocking agents on reperfusion-induced arrhythmias in the isolated perfused rat heart.J Cardiovasc Pharmac 1983;5:928–936.

    Google Scholar 

  55. Kane KA, Parratt JR, Williams FM. An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.Br J Pharmac 1984;82:349–357.

    Google Scholar 

  56. Ribeiro LGT, Brandon TA, Debauche TL, Maroko PR, Miller RR. Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion.Am J Cardiol 1981;48:69–74.

    PubMed  Google Scholar 

  57. Gennaro di M, Carbonin PU. Intracellular calcium and ventricular tachyarrhythmias. In: Zanchetti A, Krikler DM, eds.Calcium antagonism in cardiovascular therapy. Experience with verapamil. Amsterdam: Excerpta Medica, 1981. Pp. 173–175.

    Google Scholar 

  58. Marshall RJ. The antiarrhythmic, hemodynamic and metabolic effects of a new antianginal agent bepridil, in the early stages of canine acute myocardial infarction.Br J Pharmac !981;72:114–120.

    Google Scholar 

  59. Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.Circulation 1981;63:70–79.

    PubMed  Google Scholar 

  60. Sugiyama S, Ozawa T, Susuki S, Kato T. Effects of verapamil and propranolol on ventricular vulnerability after coronary reperfusion.J Electrocardiol 1980;13:49–58.

    PubMed  Google Scholar 

  61. Balke CW, Kaplinsky E, Michelson EL, Naito M, Dreifus LS. Reperfusion tachyarrhythmias: correlation with antecedent coronary artery occlusion arrhythmias and duration of myocardial ischemia.Am Heart J 1981;101:449–456.

    PubMed  Google Scholar 

  62. Sheehan FH, Epstein SE. Determinants of arrhythmic death during coronary artery reperfusion: effect of perfusion bed size.Am Heart J 1983;105:911–914.

    PubMed  Google Scholar 

  63. Rosen RR, Danilo P. Cellular electrophysiologic mechanisms of antiarrhythmic drug action. In: Reiser HJ, Horowitz LN, eds.Mechanisms and treatment of cardiac arrhythmias; relevance of basic studies to clinical management. Baltimore, Munich: Urban & Schwarzenberg, 1985. Pp. 71–88.

    Google Scholar 

  64. LeMarec H, Dangman KH, Danilo P, Rosen MR. An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction.Circulation 1985;71:1224–1236.

    PubMed  Google Scholar 

  65. Friedman PL, Stewart JR, Wit AL. Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs.Circ Res 1973;33:612–626.

    PubMed  Google Scholar 

  66. Watts JA, Koch CD, LaNoue KF. Effects of Ca2+ antagonism on energy metabolism: Ca2+ and heart function after ischemia.Am J Physiol 1980;238:H909-H916.

    PubMed  Google Scholar 

  67. Ferrari R, Ceconi C, Curello S, Cargnoni A, Agnoletti G, Boffa GM, Visioli O. Intracellular effects of myocardial ischaemia and reperfusion: role of calcium and oxygen.Eur Heart J 1986;7(supplA):3–12.

    Google Scholar 

  68. Kaplinsky E, Ogawa S, Michelson EL, Dreifus LS. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms.Circulation 1981;63:333–340.

    PubMed  Google Scholar 

  69. Miura T, Yellon DM, Hearse DJ, Downey JM. Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog.J Am Coll Cardiol 1987;9:647–654.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Cardiology-Angiology, University Hospital, Albert-Schweitzer-Strasse 33, D-4400, Muenster, West Germany

    Hartmut Gülker M.D., Wilhelm Haverkamp, Gerhard Hindricks & Franz Bender

Authors
  1. Hartmut Gülker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilhelm Haverkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerhard Hindricks
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Franz Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gülker, H., Haverkamp, W., Hindricks, G. et al. Calcium antagonists and acute myocardial ischemia: Comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. Cardiovasc Drug Ther 1, 367–376 (1987). https://doi.org/10.1007/BF02209078

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02209078

Key words

  • calcium antagonists
  • gallopamil
  • nifedipine
  • ventricular arrhythmias
  • ischemia
  • reperfusion